Literature DB >> 17162606

Extended oligoarthritis and other risk factors for developing JIA-associated uveitis under ILAR classification and its implication for current screening guideline.

Kuan T Sim1, Helen E Venning, Steve Barrett, Richard M Gregson, Winfred M Amoaku.   

Abstract

PURPOSE: To investigate the risk factors for developing uveitis in a regional cohort of patients with juvenile idiopathic arthritis (JIA) as classified under ILAR criteria. PATIENTS AND METHODS: The clinical factors for developing uveitis and its visual outcome were studied retrospectively for all children diagnosed with JIA at Nottingham University Hospital, England from 1974 to 2001.
RESULTS: A total of 202 patients with juvenile idiopathic arthritis were identified. Twenty-three patients (11.4%) were found to have uveitis. The mean age of arthritis onset in those with uveitis was 4.9 (95% CI 3.4-6.4) and in those without uveitis was 7.6 (95% CI 7.0-8.3), p = 0.002. Both the persistent and extended oligoarthritis groups are at significant risk of developing uveitis on Kaplan-Meier analysis with p = 0.001 and 0.013, respectively, compared to other ILAR subtypes. Extended oligoarthritis (1 to 4 joints affected in first 6 months of disease but 5 or more cumulative joints after first 6 months) had the highest prevalence of uveitis (25%) among the ILAR subtypes. Patients with extended oligoarthritis also developed uveitis earlier than persistent group, p = 0.017. Gender, race, and antinuclear antibody (ANA) status were not significant risk factors. The visual outcome was favorable, with 90% achieving acuity of 6/12 or better.
CONCLUSION: Patients with extended oligoarthritis are at higher risk and have a shorter interval from diagnosis of arthritis to development of uveitis and need to be monitored more closely. Screening guideline for JIA-associated uveitis based on ILAR classification is called for.

Entities:  

Mesh:

Year:  2006        PMID: 17162606     DOI: 10.1080/09273940600977233

Source DB:  PubMed          Journal:  Ocul Immunol Inflamm        ISSN: 0927-3948            Impact factor:   3.070


  10 in total

Review 1.  Emerging role of antioxidants in the protection of uveitis complications.

Authors:  U C S Yadav; N M Kalariya; K V Ramana
Journal:  Curr Med Chem       Date:  2011       Impact factor: 4.530

Review 2.  Uveitis associated with juvenile idiopathic arthritis.

Authors:  Ethan S Sen; Andrew D Dick; Athimalaipet V Ramanan
Journal:  Nat Rev Rheumatol       Date:  2015-03-31       Impact factor: 20.543

3.  Uveitis Is a Risk Factor for Juvenile Idiopathic Arthritis' Significant Flare in Patients Treated With Biologics.

Authors:  Mikhail M Kostik; Ekaterina V Gaidar; Lubov S Sorokina; Ilya S Avrusin; Tatiana N Nikitina; Eugenia A Isupova; Irina A Chikova; Yuri Yu Korin; Elizaveta D Orlova; Ludmila S Snegireva; Vera V Masalova; Margarita F Dubko; Olga V Kalashnikova; Vyacheslav G Chasnyk
Journal:  Front Pediatr       Date:  2022-06-15       Impact factor: 3.569

4.  Uveitis and juvenile idiopathic arthritis: A cohort study.

Authors:  David BenEzra; Evelyne Cohen; Francine Behar-Cohen
Journal:  Clin Ophthalmol       Date:  2007-12

5.  Risk markers of juvenile idiopathic arthritis-associated uveitis in the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry.

Authors:  Sheila T Angeles-Han; Christina F Pelajo; Larry B Vogler; Kelly Rouster-Stevens; Christine Kennedy; Lori Ponder; Courtney McCracken; Jorge Lopez-Benitez; Carolyn Drews-Botsch; Sampath Prahalad
Journal:  J Rheumatol       Date:  2013-11-01       Impact factor: 4.666

6.  Updates on the risk markers and outcomes of severe juvenile idiopathic arthritis-associated uveitis.

Authors:  Sheila T Angeles-Han; Steven Yeh; Larry B Vogler
Journal:  Int J Clin Rheumtol       Date:  2013-02-01

7.  Visual Function And Quality Of Life In A Cohort Of Swedish Children With Juvenile Idiopathic Arthritis.

Authors:  Rezhna Taha; Maria Papadopoulou; Madeleine Zetterberg; Solveig Oskarsdottir; Marita Andersson Grönlund
Journal:  Clin Ophthalmol       Date:  2019-10-24

8.  Long-term efficacy of adalimumab in the treatment of uveitis associated with juvenile idiopathic arthritis.

Authors:  Kaisu Kotaniemi; Hanna Säilä; Hannu Kautiainen
Journal:  Clin Ophthalmol       Date:  2011-10-03

9.  Consensus-based recommendations for the management of uveitis associated with juvenile idiopathic arthritis: the SHARE initiative.

Authors:  Tamas Constantin; Ivan Foeldvari; Jordi Anton; Joke de Boer; Severine Czitrom-Guillaume; Clive Edelsten; Raz Gepstein; Arnd Heiligenhaus; Clarissa A Pilkington; Gabriele Simonini; Yosef Uziel; Sebastian J Vastert; Nico M Wulffraat; Anne-Mieke Haasnoot; Karoline Walscheid; Annamária Pálinkás; Reshma Pattani; Zoltán Györgyi; Richárd Kozma; Victor Boom; Andrea Ponyi; Angelo Ravelli; Athimalaipet V Ramanan
Journal:  Ann Rheum Dis       Date:  2018-03-28       Impact factor: 19.103

10.  Impact of Antiinflammatory Treatment on the Onset of Uveitis in Juvenile Idiopathic Arthritis: Longitudinal Analysis From a Nationwide Pediatric Rheumatology Database.

Authors:  Christoph Tappeiner; Sandra Schenck; Martina Niewerth; Arnd Heiligenhaus; Kirsten Minden; Jens Klotsche
Journal:  Arthritis Care Res (Hoboken)       Date:  2016-01       Impact factor: 4.794

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.